Please note that results vary by individual, and outcomes cannot be guaranteed
The medication, licensed by the MHRA for type 2 diabetes management, with a separate GB licence for weight management, works primarily through glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonism
NICE guidance acknowledges that response to treatment varies between individuals
AARP reports 40% of respondents feel the medication is too expensive and 27% say they could not afford it
Methods Aim, design, and setting We aimed to clarify the association between endometriosis and perinatal complications and investigate whether there is a significant difference in the incidence of these complications depending on the degree of surgical completion of endometriosis
Our platform is designed to provide ongoing support throughout your treatment